acute lymphoblastic leukaemia/lymphoblastic lymphoma
Categories:
Current SOPs
| SOP Numbers | Date of Commencement | Incorporated Material | Status | |
|---|---|---|---|---|
| Reasonable Hypothesis | ||||
| 30/05/2022 | Current | Compilation | ||
| SOP Numbers | Date of Commencement | Incorporated Material | Status | |
|---|---|---|---|---|
| Balance of Probabilities | ||||
| 05/04/2021 | Current | Principal | ||
Past Versions of SOPs
| SOP Numbers | Date of Commencement | Status | ||
|---|---|---|---|---|
| Reasonable Hypothesis | Balance of Probabilities | |||
| 30/05/2022 | Current | Amendment | ||
| 05/04/2021 | Current | Principal | ||
| previously known as: acute lymphoblastic leukaemia | ||||
| 18/09/2017 | Revoked | Amendment | ||
| 18/09/2017 | Revoked | Compilation | ||
| 04/04/2016 | Revoked | Amendment | ||
| 31/10/2012 | Revoked | Principal | ||
| previously known as: acute lymphoid leukaemia | ||||
| 17/10/2001 | Revoked | Principal | ||
| 01/03/1995 | Revoked | Principal | ||
Other Information
| Subject | Documents | Relevant SOPs | Date | Comment |
|---|---|---|---|---|
| Reference List | 59/2022 | 12/04/2022 | ||
| Amendment Explanatory Statements tabled in Houses of Parliament | 59/2022 | 29/04/2022 | ||
| Explanatory Statements tabled in Houses of Parliament | 33/2021 34/2021 | 05/04/2021 |